OX3 Stock Chart & Stats
€33.20
€0.80(2.30%)
At close: 4:00 PM EDT
€33.20
€0.80(2.30%)
Day’s Range― - ―
52-Week Range€20.00 - €38.40
Previous CloseN/A
Volume0.00
Average Volume (3M)18.00
Market Cap
€1.73B
Enterprise Value€1.55B
Total Cash (Recent Filing)€106.90M
Total Debt (Recent Filing)€44.50M
Price to Earnings (P/E)31.5
Beta0.97
Next Earnings
Nov 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.86
Shares Outstanding54,911,312
10 Day Avg. Volume55
30 Day Avg. Volume18
Financial Highlights & Ratios
PEG Ratio0.32
Price to Book (P/B)4.02
Price to Sales (P/S)3.23
P/FCF Ratio28.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€37.32Price Target Upside12.42% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
EPS Forecast (FY)0.01
Revenue Forecast (FY)€5.16M
Bulls Say, Bears Say
Bulls Say
Order Momentum And VisibilityStrong order growth and a materially larger order book improve forward revenue visibility. The early FY27 multiyear order further supports planned growth and reduces reliance on winning and delivering entirely new projects each quarter.
Resilient Margins And Cost ActionsHealthy margins indicate differentiated, high-value products and pricing power in specialist markets. Restructuring savings and ongoing operational improvements can help sustain profitability while the company invests in growth and manufacturing capacity.
Conservative Balance SheetLow leverage limits financial risk and preserves flexibility to fund capital expenditure, research and development, or strategic opportunities. This balance-sheet capacity is particularly valuable while demand and project timing remain uneven.
Bears Say
Revenue Decline And Timing RiskThe gap between orders and recognized revenue shows that growth depends on customer readiness, production execution and shipment timing. Persistent lumpiness can make results less predictable and delay the conversion of strong bookings into cash.
Volatile Cash-Flow QualityPositive cash generation is encouraging, but reliance on one-off benefits and swings in earnings conversion reduce predictability. Weaker underlying operating cash flow could constrain self-funded investment if working capital or tax benefits reverse.
Execution And Scaling ConstraintsCapacity and customer-readiness constraints could limit the company’s ability to convert Advanced Technologies demand into near-term shipments. Delayed scaling would defer revenue, dilute operating leverage and increase the risk of missed growth expectations.
Oxford Instruments News
OX3 FAQ
What was Oxford Instruments PLC’s price range in the past 12 months?
Oxford Instruments PLC lowest stock price was €20.00 and its highest was €38.40 in the past 12 months.
What is Oxford Instruments PLC’s market cap?
Oxford Instruments PLC’s market cap is €1.73B.
When is Oxford Instruments PLC’s upcoming earnings report date?
Oxford Instruments PLC’s upcoming earnings report date is Nov 10, 2026 which is in 63 days.
How were Oxford Instruments PLC’s earnings last quarter?
Oxford Instruments PLC released its earnings results on Jun 09, 2026. The company reported €0.749 earnings per share for the quarter, beating the consensus estimate of €0.722 by €0.027.
Is Oxford Instruments PLC overvalued?
According to Wall Street analysts Oxford Instruments PLC’s price is currently Undervalued.
Does Oxford Instruments PLC pay dividends?
Oxford Instruments PLC does not currently pay dividends.
What is Oxford Instruments PLC’s EPS estimate?
Oxford Instruments PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oxford Instruments PLC have?
Oxford Instruments PLC has 54,911,312 shares outstanding.
What happened to Oxford Instruments PLC’s price movement after its last earnings report?
Oxford Instruments PLC reported an EPS of €0.749 in its last earnings report, beating expectations of €0.722. Following the earnings report the stock price went up 0.563%.
Which hedge fund is a major shareholder of Oxford Instruments PLC?
Currently, no hedge funds are holding shares in DE:OX3
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Oxford Instruments Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€37.32 (12.42% Upside)
€37.32 (12.42% Upside)
Blogger Sentiment
Bearish
DE:OX3 Sentiment 100%
Sector Average 60%
Sector Average 60%
Insider Transactions
Sold Shares
Worth €360.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
53.05%
12-Months-Change
Fundamentals
Return on Equity
0.82%
Trailing 12-Months
Asset Growth
-6.74%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Oxford Instruments PLC
Established in 1959 and headquartered in Abingdon, UK, Oxford Instruments plc operates as a global technology enterprise dedicated to the innovation, development, manufacturing, rental, sale, and maintenance of sophisticated scientific instruments and systems. Its global footprint extends across the United Kingdom, China, Japan, the United States, Germany, the broader European continent, and the rest of Asia, serving international markets. The company's operations are divided into three core business units: Materials & Characterisation, Research & Discovery, and Service & Healthcare. The extensive product lineup includes advanced atomic force microscopy devices, along with vital tools for research and development that serve a wide array of sectors, including semiconductors, renewable energy, mining, metallurgy, and forensic science. It also supplies specialized etch and deposition processing equipment and solutions critical for applications in power and radio frequency devices, VCSELs/lasers, two-dimensional materials, augmented reality, biomems, failure analysis, HBLEDs, infrared sensors, MEMS/sensors, and quantum technologies. Furthermore, Oxford Instruments offers a comprehensive range of low-temperature systems, encompassing wet and magnet systems, advanced instrumentation, and bespoke custom solutions. The company's portfolio also features optical imaging products; Nuclear Magnetic Resonance (NMR) instruments, including spectrometers, quality control/assurance analyzers, and rock core analyzers, which are indispensable across diverse fields such as agriculture, food, automotive, aviation, construction, chemicals, environmental science, illicit drug testing, mining, pharmaceuticals, polymers, rock core analysis, textiles, and educational institutions. The enterprise also provides support products for MRI and CT imaging technologies, alongside scientific cameras, spectroscopy solutions, microscopy systems, and proprietary software. These are integral to applications in astronomy, bio-imaging and life sciences, energy generation and storage, forensics and environmental monitoring, photonics, quantum technology, semiconductors, microelectronics, and data storage. Moreover, Oxford Instruments manufactures X-ray tubes, power supplies, and integrated X-ray sources, catering to the analytical, medical imaging, food quality and packaging inspection, and industrial non-destructive testing (NDT) markets.
OX3 Company Deck
OX3 Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
Positive: The call highlighted meaningful strategic progress, strong order momentum (notably AT +28% and a 25% larger year-end order book), high cash conversion (89%), margin improvement actions (Belfast restructuring and FY '25 restatement), and clear FY '27 revenue guidance (AT high-teens growth; I&A low single-digit). Challenges remain — revenue was down ~3% due to timing/lumpiness, some product-line softness, FX headwinds, and near-term execution/ramp constraints — but management provided credible operational fixes, balance sheet optionality (£42m NanoScience proceeds and a £100m buyback), and forward-looking investment plans. On balance, highlights and forward visibility materially outweigh the lowlights, supporting a positive outlook.View all DE:OX3 earnings summariesOX3 Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€37.32
▲(12.42% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month








